吉林敖东药业集团延吉股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
158
NMPA:158
Drug Approvals
Polyvinyl Alcohol Eye Drops
- Product Name
- 聚乙烯醇滴眼液
- Approval Number
- 国药准字H20253659
- Approval Date
- Mar 18, 2025
NMPA
Amlodipine Besilate Tablets
- Product Name
- 苯磺酸氨氯地平片
- Approval Number
- 国药准字H20249573
- Approval Date
- Dec 1, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20249056
- Approval Date
- Oct 16, 2024
NMPA
Ribonucleic Acid for Injection
- Product Name
- 注射用核糖核酸
- Approval Number
- 国药准字H20003468
- Approval Date
- Feb 1, 2024
NMPA
Methionine and Vitamin B1 Injection
- Product Name
- 甲硫氨酸维B1注射液
- Approval Number
- 国药准字H20065556
- Approval Date
- Jan 4, 2024
NMPA
Ribonucleic Acid for Injection
- Product Name
- 注射用核糖核酸
- Approval Number
- 国药准字H20003467
- Approval Date
- Dec 19, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found